loading
Schlusskurs vom Vortag:
$2.08
Offen:
$2.18
24-Stunden-Volumen:
58,926
Relative Volume:
0.28
Marktkapitalisierung:
$7.70M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-15.47M
KGV:
-4.28
EPS:
-0.5
Netto-Cashflow:
$-13.51M
1W Leistung:
+5.42%
1M Leistung:
-18.63%
6M Leistung:
+41.72%
1J Leistung:
-61.51%
1-Tages-Spanne:
Value
$2.12
$2.20
1-Wochen-Bereich:
Value
$1.80
$2.24
52-Wochen-Spanne:
Value
$1.30
$5.95

Nls Pharmaceutics Ltd Stock (NLSP) Company Profile

Name
Firmenname
Nls Pharmaceutics Ltd
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
1
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
NLSP's Discussions on Twitter

Vergleichen Sie NLSP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NLSP
Nls Pharmaceutics Ltd
2.14 8.84M 0 -15.47M -13.51M -0.50
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
376.62 97.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
576.98 60.19B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
458.37 59.56B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
729.76 44.94B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
329.84 36.14B 3.81B -644.79M -669.77M -6.24

Nls Pharmaceutics Ltd Aktie (NLSP) Neueste Nachrichten

pulisher
Sep 22, 2025

What’s next for NLS Pharmaceutics AG Equity Warrant stock priceWeekly Market Report & Verified Stock Trade Ideas - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Using economic indicators to assess NLS Pharmaceutics AG Equity Warrant potentialWeekly Risk Summary & Scalable Portfolio Growth Methods - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Is NLS Pharmaceutics AG stock ready for a breakoutTrade Analysis Summary & Weekly High Return Stock Opportunities - newser.com

Sep 22, 2025
pulisher
Sep 21, 2025

Market reaction to NLS Pharmaceutics AG Equity Warrant’s recent newsJuly 2025 Breakouts & Expert Approved Momentum Trade Ideas - newser.com

Sep 21, 2025
pulisher
Sep 21, 2025

Custom strategy builders for tracking NLS Pharmaceutics AGMarket Performance Report & AI Enhanced Market Trend Forecasts - newser.com

Sep 21, 2025
pulisher
Sep 20, 2025

Rally Mode: Does NLS Pharmaceutics AG stock benefit from AI growthPrice Action & Low Risk Growth Stock Ideas - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Visual trend scoring systems applied to NLS Pharmaceutics AG Equity WarrantJuly 2025 Big Picture & Smart Allocation Stock Tips - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

What data driven models say about NLS Pharmaceutics AG Equity Warrant’s futureJuly 2025 Analyst Calls & Weekly Stock Breakout Alerts - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

What the charts say about NLS Pharmaceutics AG Equity Warrant todayNew Guidance & Free Accurate Trade Setup Notifications - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

How moving averages guide NLS Pharmaceutics AG tradingTreasury Yields & High Accuracy Trade Signal Alerts - newser.com

Sep 20, 2025
pulisher
Sep 19, 2025

Chart based exit strategy for NLS Pharmaceutics AGProfit Target & Intraday High Probability Setup Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Is NLS Pharmaceutics AG stock reversal real or fakeQuarterly Portfolio Summary & Smart Swing Trading Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

What to expect from NLS Pharmaceutics AG Equity Warrant in the next 30 days2025 Price Targets & Low Drawdown Investment Strategies - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

How to track smart money flows in NLS Pharmaceutics AG Equity WarrantPortfolio Growth Summary & Real-Time Sentiment Analysis - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Bond Watch: Is NLS Pharmaceutics AG stock a buy or sellTrade Analysis Report & Intraday High Probability Alerts - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

When is the best time to exit NLS Pharmaceutics AG2025 Performance Recap & High Accuracy Trade Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

What technical models suggest about NLS Pharmaceutics AG Equity Warrant’s comeback2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Evaluating NLS Pharmaceutics AG with trendline analysis2025 Key Lessons & Weekly Top Gainers Trade List - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

NLS Pharmaceutics Engages New Accounting Firm After Marcum’s Resignation - TipRanks

Sep 19, 2025
pulisher
Sep 19, 2025

Using AI based signals to follow NLS Pharmaceutics AG Equity WarrantWeekly Trading Summary & AI Forecast Swing Trade Picks - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Sell Signal: Is NLS Pharmaceutics AG subject to activist investor interestJuly 2025 Opening Moves & Low Volatility Stock Suggestions - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

How to interpret RSI for NLS Pharmaceutics AG stock2025 Technical Patterns & Free Community Supported Trade Ideas - newser.com

Sep 19, 2025
pulisher
Sep 18, 2025

Can volume confirm reversal in NLS Pharmaceutics AGJuly 2025 Retail & Risk Managed Investment Signals - newser.com

Sep 18, 2025
pulisher
Sep 17, 2025

Will NLS Pharmaceutics AG see short term momentumQuarterly Market Review & Momentum Based Trading Signals - newser.com

Sep 17, 2025
pulisher
Sep 16, 2025

AI Stocks: Whats the outlook for NLS Pharmaceutics AGs sector2025 Macro Impact & Fast Exit Strategy with Risk Control - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

NLS Pharmaceutics AG Equity Warrant recovery potential after sell offProduct Launch & High Return Stock Watch Alerts - newser.com

Sep 16, 2025
pulisher
Sep 15, 2025

EV Market: Is NLS Pharmaceutics AG subject to activist investor interestJuly 2025 Levels & Reliable Intraday Trade Plans - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Will NLS Pharmaceutics AG Equity Warrant see short term momentumWeekly Profit Analysis & AI Forecasted Stock Moves - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Technical signs of recovery in NLS Pharmaceutics AG2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com

Sep 15, 2025

Finanzdaten der Nls Pharmaceutics Ltd-Aktie (NLSP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$35.77
price down icon 1.30%
$84.16
price down icon 0.45%
$29.45
price up icon 2.51%
$99.75
price up icon 1.51%
$141.00
price down icon 3.01%
biotechnology ONC
$329.84
price up icon 0.23%
Kapitalisierung:     |  Volumen (24h):